Synthesis and pharmacology of a novel anti-inflammatory agent, ID-1619.
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D001168:Arthritis / Q000188:drug therapy; D002199:Capillary Permeability / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D002934:Cinnamates; D004487:Edema / Q000188:drug therapy; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006099:Granuloma / Q000188:drug therapy; D007210:Indoleacetic Acids; D007213:Indomethacin / Q000627:therapeutic use; D007416:Intestinal Perforation / Q000139:chemically induced; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D010653:Phenylbutazone / Q000627:therapeutic use; D010659:Phenylhydrazines; D011817:Rabbits; D051381:Rats; D012871:Skin Diseases / Q000188:drug therapy
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D002934:Cinnamates; D007210:Indoleacetic Acids; D010659:Phenylhydrazines; D010653:Phenylbutazone; D007213:Indomethacin